Effect of High Stanol Ester Dose on Serum Lipids, Carotenoids and Fat-soluble Vitamins
NCT ID: NCT00698256
Last Updated: 2012-04-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2008-02-29
2008-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Plant Stanols on Cholesterol Absorption
NCT00441857
Effect of Plant Stanol Esters on Blood Lipids
NCT00920894
Long Term Effects of Plant Sterol and Stanol Esters
NCT00802516
Lipid Lowering Effect of Plant Stanol Ester in a Spoonable Non-dairy Product
NCT05064644
Lipid Lowering Effect of Plant Stanol Ester in a Drinkable Non-dairy Product
NCT05126056
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In humans, the metabolism of plant sterols and stanols is not completely known. Recently, we showed that plant sterols are esterified in enterocytes as well as cholesterol facilitating their transport in lipoproteins. However, it is not known, how consumption of high doses of stanol esters affect the metabolism of plant sterols in enterocytes and their transport. This is important to know, when new foodstuffs enriched with plant sterols or stanols for cholesterol-lowering are developed.
In this study, the aim was to investigate the effects of the consumption of high doses of plant stanol esters on concentrations of serum lipids, carotenoids and fat soluble vitamins. In addition, we investigated the metabolism of absorbed plant sterols from intestine without and with the consumption of plant stanol esters.
Altogether 50 subjects with normo- or hypercholesterolemia (total cholesterol 4.5-7.5 mmol/l) were recruited to the study from an announcement in the local newspaper. The study is carried out with a randomized, double-blind and parallel design. The intervention group (n=25) consumes spread and oat drink enriched with plant stanol esters (9 g/d stanols) and the control group (n=25) the same product containing no added stanols for 10 weeks. The fasting blood samples are taken at weeks 0, 9, 10 and 14 (4 weeks after the end of the test product consumption). At week 10, an oral postprandial test is performed in 40 subjects in order to study the postprandial metabolism of plant sterols. From blood samples blood count and levels of serum liver enzymes (0 and 10 wk), concentrations of serum lipids, squalene and non-cholesterol sterols, α and β carotenoids, fat soluble vitamins A, E and D (0, 9 and 10 wk) and serum squalene and non-cholesterol sterols (14 wk) will be analyzed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
vegetable oil-based spread and oat-based drink (no brand name available)
spread and drink (9 g stanols/d)
2
vegetable oil-based spread and oat-based drink (no brand name available)
Spread and drink (not containing added stanols)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
vegetable oil-based spread and oat-based drink (no brand name available)
spread and drink (9 g stanols/d)
vegetable oil-based spread and oat-based drink (no brand name available)
Spread and drink (not containing added stanols)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18-75 years
Exclusion Criteria
* Unstable coronary disease
* Inflammatory bowel disease
* Medication for hypercholesterolemia
* Plant stanol/sterol enriched foods
18 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Raisio Plc
INDUSTRY
Marjukka Kolehmainen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marjukka Kolehmainen
Senior scientist
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of kuopio
Kuopio, , Finland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Hallikainen M, Simonen P, Gylling H. Cholesterol metabolism and serum non-cholesterol sterols: summary of 13 plant stanol ester interventions. Lipids Health Dis. 2014 Apr 27;13:72. doi: 10.1186/1476-511X-13-72.
Gylling H, Hallikainen M, Nissinen MJ, Miettinen TA. The effect of a very high daily plant stanol ester intake on serum lipids, carotenoids, and fat-soluble vitamins. Clin Nutr. 2010 Feb;29(1):112-8. doi: 10.1016/j.clnu.2009.08.005. Epub 2009 Aug 26.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
132\\2007
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.